Generali Asset Management SPA SGR Trims Stock Position in Corteva, Inc. $CTVA

Generali Asset Management SPA SGR lessened its stake in Corteva, Inc. (NYSE:CTVA) by 20.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 41,219 shares of the company’s stock after selling 10,494 shares during the period. Generali Asset Management SPA SGR’s holdings in Corteva were worth $2,763,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. ASR Vermogensbeheer N.V. acquired a new stake in Corteva in the 4th quarter valued at approximately $4,448,000. MGO One Seven LLC increased its holdings in Corteva by 23.9% in the 4th quarter. MGO One Seven LLC now owns 12,188 shares of the company’s stock valued at $817,000 after purchasing an additional 2,353 shares during the last quarter. Crestwood Advisors Group LLC increased its holdings in Corteva by 6.2% in the 4th quarter. Crestwood Advisors Group LLC now owns 8,849 shares of the company’s stock valued at $593,000 after purchasing an additional 514 shares during the last quarter. Sequoia Financial Advisors LLC increased its holdings in Corteva by 19.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 34,143 shares of the company’s stock valued at $2,289,000 after purchasing an additional 5,569 shares during the last quarter. Finally, Fire Capital Management LLC increased its holdings in Corteva by 7.8% in the 4th quarter. Fire Capital Management LLC now owns 12,561 shares of the company’s stock valued at $842,000 after purchasing an additional 914 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 2.6%

CTVA opened at $81.10 on Friday. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The company has a market cap of $54.24 billion, a P/E ratio of 47.70, a PEG ratio of 2.77 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.47. The business’s 50-day simple moving average is $80.68 and its 200-day simple moving average is $72.61.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the prior year, the business posted $1.13 EPS. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 3.67 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is 42.35%.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Royal Bank of Canada raised Corteva’s price target to $97 from $95 and kept an outperform rating, signaling confidence in roughly 20% upside from recent levels. RBC Capital adjusts Corteva price target to $97 from $95, maintains outperform rating
• Positive Sentiment: Jefferies also increased its target on Corteva to $97 from $95, reinforcing a bullish view on the stock’s longer-term valuation. Jefferies adjusts price target on Corteva to $97 from $95
• Neutral Sentiment: UBS raised its target to $90 from $88 but kept a neutral rating, suggesting limited near-term conviction despite modest upside potential. UBS Group AG price target raise
• Neutral Sentiment: Citigroup lifted its target to $85 from $83 and maintained a neutral rating, indicating some valuation support but no strong bullish call. Citigroup Inc. price target raise
• Neutral Sentiment: Corteva said CEO Chuck Magro and CFO David Johnson will speak at the BMO Global Farm to Market Conference on May 14, a routine investor-relations event with limited immediate impact. Corteva to Participate in BMO Global Farm to Market Conference
• Neutral Sentiment: BNP Paribas Exane nudged its target higher to $77 from $74 but still implied downside from the stock’s recent trading range, making it a mixed signal. BNP Paribas adjusts price target on Corteva to $77 from $74

Analysts Set New Price Targets

CTVA has been the subject of several research reports. The Goldman Sachs Group lifted their target price on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and lifted their target price for the company from $75.00 to $77.00 in a report on Thursday, February 5th. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. CICC Research lifted their target price on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. Finally, Rothschild & Co Redburn lifted their target price on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Thirteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.05.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.15% of the stock is owned by company insiders.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.